Journal article
Economic burden of malignant blood disorders across Europe: A population-based cost analysis
- Abstract:
-
Background: Malignant blood disorders are a leading contributor to cancer incidence and mortality across Europe. Despite their burden, no study has assessed the economic effect of blood cancers in Europe. We aimed to assess the economic burden of malignant blood disorders across the 28 countries in the European Union (EU), Iceland, Norway, and Switzerland.
Methods: Malignant blood disorder-related costs were estimated for 28 EU countries, Iceland, Norway, and Switzerland for 2012. C...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 1.7MB)
-
- Publisher copy:
- 10.1016/S2352-3026(16)30062-X
Authors
Funding
Eureopan Hematology Association
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Haematology Journal website
- Volume:
- 3
- Issue:
- 8
- Pages:
- 362-370
- Publication date:
- 2016-07-22
- Acceptance date:
- 2016-07-09
- DOI:
- ISSN:
-
2352-3026
Item Description
- Keywords:
- Pubs id:
-
pubs:637685
- UUID:
-
uuid:3de664aa-132e-4e21-a05c-3ae3bbc5463b
- Local pid:
- pubs:637685
- Source identifiers:
-
637685
- Deposit date:
- 2016-08-11
Terms of use
- Copyright holder:
- © 2016 Elsevier Ltd All rights reserved
- Copyright date:
- 2016
- Notes:
- This is the author accepted manuscript following peer review version of the article. The final version is available online from Elsevier at: 10.1016/S2352-3026(16)30062-X
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record